… of the phase 3 MIRASOL trial (NCT04209855) investigating mirvetuximab soravtansine … positive, platinum-resistant ovarian cancer. This study found that treatment-emergent ocular adverse … exciting because the goal of ovarian cancer treatment is for patients to …

… ovarian cancer, has been launched. The development … trial that plans to enroll 90 patients with recurrent, platinum-resistant ovarian cancer … medications—nab-paclitaxel and [Avastin]—will offer patients an additional treatment … with the drug is intended …

… and development of medications to treat severe … ovarian cancer. BELLA is a single-arm, open-label trial … drug by the FDA and the European Commission (EC) for the treatment … treatment of ovarian cancer. About Platinum-Resistant Ovarian Cancer Ovarian cancer …

… against specific anticancer drugs to identify which drugs are likely … -guided treatments may relieve financial toxicity, especially for ovarian cancer patients … in recurrent platinum-resistant ovarian cancer randomized clinical trial. npj Precision Oncology. …

… them in clinical development [in ovarian cancer and other … FDA approval of mirvetuximab soravtansine-gynx (Elahere) for the treatment … PanTumor03 trial (NCT05489211), patients with platinum-sensitive ovarian cancer … right drug and the right sequence of drugs …

… select targeted treatments for patients with platinum-resistant ovarian cancer, based on … in a randomized trial of patients with recurrent ovarian cancer,” added Herzog … recurrent platinum-resistant ovarian cancer randomized clinical trial. NPJ Precis Oncol. …

… standard diagnostic test for ovarian cancer is less effective in … in patients’ blood. Its development in the 1980s relied … potentially leading to delayed treatment and poor outcomes.  Native … more inclusive approach to developing diagnostic tools.  Haring and …

… the challenge of treating this form of … Paolo Claudio, who co-developed this innovative clinical test … medicine into treatment frameworks for ovarian cancer and potentially … platinum-resistant ovarian cancer randomized clinical trial News Publication Date …

… its efficacy in the treatment of ovarian cancer. “This trial represents an important step … University of Iowa College of Pharmacy, builds upon Markey Cancer Center … . The Kentucky Tobacco Research and Development Center at the UK Martin …

… the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of increasing … resistant ovarian cancer patients remain a very difficult group to treat, and … development for the treatment of solid tumors, certain types of sarcoma, and ovarian cancer …